CUSIP 35104E100COMFDMTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
151 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 5.65M | $42.40M | +1.09M | Added |
| 2 | Janus Henderson Group PLC | 4.64M | $34.73M | +2.88M | Added |
| 3 | Bvf Inc/Il | 4.63M | $34.72M | 0 | Held |
| 4 | Goldman Sachs Group Inc | 4.30M | $32.27M |
| +174.5K |
| Added |
| 5 | Blackrock, Inc. | 4.06M | $30.49M | +195.7K | Added |
| 6 | Novo Holdings A/S | 3.65M | $27.38M | +1.65M | Added |
| 7 | Vanguard Group Inc | 3.09M | $23.20M | +518.4K | Added |
| 8 | State Street Corp | 2.69M | $20.17M | +1.79M | Added |
| 9 | Armistice Capital, LLC | 1.94M | $14.52M | +840.0K | Added |
| 10 | Federated Hermes, Inc. | 1.61M | $12.07M | +14.7K | Added |
See every fund holding 4d Molecular Therapeutics In, with full quarter-over-quarter share changes.
Unlock all holders